WST — West Pharmaceutical Services Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for West Pharmaceutical Services, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	439	616	763	894	854
Net Total Accounts Receivable
Net Total Receivables	319	385	489	507	512
Total Inventory
Total Other Current Assets
Total Current Assets	1,059	1,374	1,742	1,920	1,936
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	909	1,012	1,127	1,263	1,513
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	2,341	2,794	3,314	3,617	3,830
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	342	503	594	519	672
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	768	939	978	932	949
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	1,573	1,855	2,335	2,685	2,881
Total Liabilities & Shareholders' Equity	2,341	2,794	3,314	3,617	3,830
Total Common Shares Outstanding